Mandate

Vinge advises Gränges in conjunction with acquisition of Aluminium Konin

November 28, 2019

Vinge has advised Gränges AB (publ) in connection with the acquisition of Aluminium Konin, a Polish aluminium manufacturer, for SEK 2.3 billion from Boryszew Group. In connection with the transaction, Gränges intends to perform a rights issue for SEK 2 billion. In order to finance the acquisition, Gränges has entered into a bridge financing facility agreement with certain Nordic banks for SEK 2.3 billion.

Gränges is a leading global supplier of rolled aluminium products for heat exchanger applications and other niche markets in Europe, Asia and the United States. The company has a turnover of approximately SEK 13 billion and has approximately 1,800 employees. Aluminium Konin is a Polish manufacturer of rolled aluminium, with a turnover of SEK 3 billion and has approximately 750 employees.

The transaction is conditional upon the consent of the relevant competition authorities.

Vinge’s team primarily consist of Kristian Ford (M&A) together with Pär Remnelid, Johan Wahlbom and Julia Söderdahl (Competition Law), Jesper Schönbeck, Rikard Lindahl and Joel Wahlberg (Capital Markets) as well as Louise Brorsson Salomon and Axel Jansson (Banking and Finance).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025